Wang, J., Wang, L., Duan, X., Liu, F., Yang, F., Xu, B. (2025). Matching-adjusted indirect comparison of bireociclib plus fulvestrant versus abemaciclib plus fulvestrant as second-line treatment of HR+/HER2− advanced breast cancer.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.e15141